|
|
|
|
LEADER |
00000cam a22000008a 4500 |
001 |
b1327239 |
003 |
MWH |
005 |
19940520101805.0 |
008 |
921102s1992 enka 001 0 eng d |
010 |
|
|
|a gb 92047499
|
015 |
|
|
|a GB92-47499
|
019 |
|
|
|a 27032496
|a 27108992
|
020 |
|
|
|a 0123223709 :
|c £40.00
|
035 |
|
|
|a (OCoLC)27071306
|
040 |
|
|
|a UKM
|c UKM
|d CUY
|d MDU
|d KKU
|d AGL
|d PIT
|d BNB
|d MMU
|d HCQ
|
049 |
|
|
|a HCQS
|
070 |
0 |
|
|a QP801.S4C45
|b 1992
|
072 |
|
0 |
|a L600
|
090 |
|
|
|a QP801.S4 C45 1992
|
096 |
|
|
|a QU 60
|f HAM
|
245 |
0 |
0 |
|a Central and peripheral 5-HT3 receptors /
|c edited by M. Hamon.
|
260 |
|
|
|b Academic Press,
|c c1992.
|
300 |
|
|
|a xiii, 314 p. :
|b ill. ;
|c 24 cm.
|
650 |
|
0 |
|a Neurotransmitter receptors
|
650 |
|
0 |
|a Serotonin
|
650 |
|
0 |
|a Serotonin
|x Antagonists
|
650 |
|
0 |
|a Serotonin
|x Receptors.
|
650 |
|
0 |
|a Serotonin
|x Therapeutic use.
|
700 |
1 |
0 |
|a Hamon, M.
|q (Michel)
|
830 |
|
0 |
|a Neuroscience perspectives
|
907 |
|
|
|a .b13272391
|b 05-23-16
|c 10-03-03
|
998 |
|
|
|a hq
|b 10-01-03
|c m
|d a
|e -
|f eng
|g enk
|h 0
|i 1
|
995 |
|
|
|a MARION ACO-7844
|
945 |
|
|
|f - -
|g 1
|h 0
|i 38400001733334
|j - -
|k - -
|l hqcol
|o -
|p $0.00
|q -
|r -
|s -
|t 0
|u 0
|v 0
|w 0
|x 0
|y .i13966170
|z 10-03-03
|
999 |
f |
f |
|i cf5b1024-5733-5fb3-ba0d-8ae5993d1bec
|s 494c5f6d-ddcb-53e0-b3c2-d7aa98fc8468
|
952 |
f |
f |
|p Can Circulate
|a College of the Holy Cross
|b Main Campus
|c Science
|d Science Library
|e QP801.S4 C45 1992
|h Other scheme
|i Book
|m 38400001733334
|n 1
|